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Abstract. Risk factors for low urinary citrate excretion
were assessed in 34 consecutive male recurrent
idiopathic calcium stone formers (RCSF) who
collected two 24-h urines while on free-choice diet.
Overt hypocitraturia (hypo-cit) was denned as
UCjt x V<1.70 mmol/day, and 'low' citraturia (low-
cit) as UCltxV between 1.70 and 2.11 mmol/day.
Twenty-three RCSF had normocitraturia (normo-cit),
six low-cit and five hypo-cit. UCit x V positively
correlated with urine volume (VOLUME, r = 0.44,
P = 0.009), vegetable fibre intake (fibers, r = 0.46,
P = 0.009) and Gl-alkali absorption (alkali, r = 0.47,
P = 0.006), and volume, fibres and alkali tended to
be lower among RCSF with low-/hypo-cit. A 3-day
NH4C1 loading test (0.95 mEq/kg BW daily in 3 doses)
was performed in RCSF as well as in 14 age-matched
healthy male controls (C). On a plot of urine pH
versus serum bicarbonate, 10 of 11 RCSF with low-
/hypo-cit, but only six of 23 with normo-cit (P =
0.0004) fell off the normal range, indicating incomplete
RTA. Two or more risk factors simultaneously
occurred in only four of 23 RCSF with normo-cit, but
in eight of 11 with low-/hypo-cit (P = 0.002). In conclu-
sion, incomplete RTA is the most prevalent risk factor
for low-/hypo-cit in RCSF, and decreases in vegetable
fibres and urine volume emerge as two new risk factors
for low urinary CIT.
Key words: calcium nephrolithiasis; citrate; gastrointes-
tinal alkali absorption; renal tubular acidosis; urine
volume; vegetable fibres
Introduction
Low urinary citrate excretion is an accepted pathogenic
factor for calcium renal stone formation [1,2].
Variations of systemic acid-base status have been
shown for a long time to influence urinary citrate
excretion [3]: for instance, metabolic alkalosis increases
urinary citrate [4], whereas amrnonium-chloride-
Correspondence and offprint requests to: B. Hess MD, Policlinic of
Medicine, University Hospital, CH-3010 Berne, Switzerland.
induced acidosis lowers its excretion by 20-50% within
a few hours [5]. Owing to the fact that cytosolic
acidification activates citrate uptake by the proximal
tubular cell [3], intracellular rather than systemic acid-
osis has been postulated as the denominator common
to most patients with 'idiopathic' hypocitraturia [6].
Indeed, overt metabolic acidosis is usually absent in
recurrent calcium renal stone formers with 'idiopathic'
hypocitraturia. With the help of the classic ammonium
chloride loading test, however, we [6] and others [7]
have provided evidence for incomplete renal tubular
acidosis (RTA) in a substantial fraction of patients
with 'idiopathic' hypocitraturia. Such a reduced capab-
ility of renal acid excretion may favour intracellular
acidosis and thus cause hypocitraturia in these patients.
Dietary factors also modulate the urinary excretion
rate of citrate. Excess animal protein intake with the
acid load that it conveys lowers urinary citrate [1,8],
whereas dietary protein restriction does the opposite
[9]. Urinary citrate positively correlates with net gas-
trointestinal absorption of alkali, which seems to be
reduced in many idiopathic calcium stone formers [1].
Potassium depletion also triggers hypocitraturia [5,10]:
it appears to do so via stimulation of the sodium-
citrate cotransport system at the brush-border level of
the proximal tubular cell, and intracellular acidosis,
again, might provide the key signal [11]. Additionally,
sodium chloride loading depresses urinary citrate; this
effect may, again, be governed by intracellular acidosis,
due to sodium-induced volume expansion with sub-
sequent rise in urinary bicarbonate excretion [1].
Finally, primary intestinal malabsorption of citrate
has been postulated to account for 'idiopathic' hypoci-
traturia in some patients with idiopathic calcium
nephrolithiasis [1].
Given a population of patients with idiopathic cal-
cium nephrolithiasis studied on their free-choice diet
[12], the present study aimed to address the following
issues: (1) what is the prevalence of 'idiopathic' hypoci-
traturia?; (2) among patients who turn out to have
low urinary citrate, how often does the disorder have
a metabolic origin, and how often a nutritional one?;
(3) are there other mechanisms to account for low
urinary citrate than those alluded to above?
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Low urinary citrate and calcium nephrolithiasis
Subjects and methods
From the patients routinely seen for metabolic work-up at
our renal stone clinic, 34 consecutive male recurrent idio-
pathic calcium stone formers (RCSF) meeting the following
criteria were studied: (1) passage or removal of at least two
calcium-containing stones, defined either by stone analysis
(X-ray diffraction) or disappearance of opaque material on
conventional radiographs or excretory urograms; (2) no
established cause of calcium stone formation such as primary
hyperparathyroidism, medullary sponge kidney, overt distal
renal tubular acidosis, sarcoidosis, excessive vitamin D
intake, and hypercalciuria due to hypercalcaemia of malig-
nancy or immobilization; (3) absence of obvious causes of
hypocitraturia such as malabsorption with steatorrhoea [13],
hypokalaemia (serum K<3.5 mmol/1) due to acetazolamide
or thiazide treatment, or urinary tract infection [14]; and (4)
Ccrcm>70ml/min/1.73m
2.
Ml RCSF were referred after ESWL or endourolegical
treatment of their stone disease, and they were asked to keep
unchanged the free-choice diet they used to have before stone
treatment. They were never studied until at least 2 months
had elapsed after urological intervention. Other medications
known to interfere with calcium and citrate metabolism were
discontinued at least 2 weeks prior to evaluation.
The normal values for 24-h urinary excretion rates cur-
rently used in our stone clinic are based on 107 healthy male
volunteers living in the area of Berne, Switzerland, while on
a free-choice diet. Upper normal levels (95th percentile) are
9.00 mmol/d for calcium, 440 umol/day for oxalate, and
5.00 mmol/day for uric acid; the lower normal level of
Uc,t x V (5th percentile) is 1.70 mmol/day (320 mg/d). In an
early report by Hodgkinson [15], hypocitraturia in men had
been denned as Ua txV<2.12 mmol/day (<400mg/day);
accordingly we subclassified our RCSF into those with overt
hypocitraturia (hypo-cit), i.e. UClt x V < 1.70 mmol/day
(<320 mg/day), and those with 'low citraturia' (low-cit), i.e.
UCllxV between 1.70 and 2.11 mmol/d (320-399 mg/day).
Since the risk of calcium stone formation has been demon-
strated to increase exponentially with decreasing 24-h urine
volumes below 1200 ml [16], 'low volume' was defined as
< 1200 ml/day. All RCSF collected two 24-h urine specimens
according to our standard protocol [12]; 24-h urine values
are expressed as the means of both collections.
Twenty-four-hour urines were collected in 3-litre plastic
bottles containing 10 g of boric acid as preservative agent.
Specimens were analysed for creatinine (Crea), calcium (Ca),
phosphate (P), sodium (Na), potassium (K), chloride (Cl),
magnesium (Mg), uric acid (UA) and urea by autoanalyser
techniques. Citrate (Cit) was measured using the citrate lyase
method [17]. Oxalate (Ox) was measured after enzymatic
oxidation of oxalate by oxalate oxidase [18] as previously
described [12]. Urinary sulphate (Sulph) was measured by
an HPLC system utilizing an anion column to separate
sulphate from other urinary anions, where sulphate is
detected by conductivity change as eluent flows through a
conductivity cell [19].
Urinary excretion rates of urea, UA and Sulph were taken
as markers of animal protein consumption, and UN, x V as
a measure of sodium intake. Since fibre-rich foods such as
vegetables, grain products, and fruits are sources of alkali
[20], alkali consumption was estimated from the daily inges-
tion of vegetable fibres, subsequently referred to as 'dietary
fibres'. The latter ones were assessed from the patients' diet
protocols filled out during collections of 24-h urines, by
means of food composition and nutrition tables [20], i.e.
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two 24-h diet protocols were retrospectively analysed from
each patient; direct measurements of food compositions were
not performed. Since dietary fibre contributes 15-25 g to the
average US diet [21], ingestion of less than 15g/day was
defined as low dietary fibre intake, indicating lower alkali
consumption. Net gastrointestinal absorption of alkali
(expressed in mEq/24 h), subsequently referred to as
'Gl-alkali', was derived from 24-h urine excretions of non-
combustible cations and anions according to the formula
(Na + K + Ca + Mg)-(Cl+1.8xP) [1,22],
where electrolyte excretions are in mEq/day except for P
which is in mmol/day with an average valence of 1.8 [1,22].
Low Gl-alkali was defined as < 15 mEq/day, since the lower
normal limit (5th percentile) among our male healthy volun-
teers was 15 mEq/day.
An ammonium chloride loading study was performed in
all RCSF and additionally in 14 of our 107 healthy male
volunteers, aged 44.2 ±2.6 years (range 28-62) and with
normokalaemia (fasting serum K concentration between 3.5
and 4.1 mmol/1). It consisted of sampling venous blood and
2-h urine after 12 h without eating and 8 h without drinking
(only tap water allowed after the last meal) on day 0
(indicated as 0). From then on, ammonium chloride (NH4C1)
was added to the free-choice diet of each subject for 3 days
and given in three divided doses 20 min before each meal
(total 0.05 g/kg/day, or 0.95mEq/kg/day). On day 3, sam-
pling of fasting venous blood and 2-h urine was repeated
(indicated as 3). For the nomogram of fasting venous bicar-
bonate concentration versus urine pH after acid loading only'
(Figure 2), nine additional male healthy volunteers were
included from a previous study with NH4C1 loading [6].
Plasma concentrations of Crea, total Ca, P, Mg, Na, K,
Cl, UA, and total protein were measured by autoanalyser
techniques. Serum anion gap, an indirect index for unmeas-
ured anions, was defined as [Na+] — [C\~ +HCO3~]; normal
values were 8-16 mmol/1. In whole blood, ionized cal-
cium (Ca2+) was measured by an ion-selective electrode
(Ciba-Corning Diagnostics Corp., Medfield, Massachusetts,
USA) and bicarbonate by a Ciba-Corning 278 blood gas
system (Ciba-Corning Diagnostics Corp.) immediately after
sampling without compression. Serum intact parathyroid
hormone (PTH) concentration was measured by a radio-
immunoassay kit (Nichols Institute, San Juan Capistrano,
California, USA); normal values are 10-65 pg/ml. Serum 25
(OH) vitamin D (normal range 6—40 ng/ml) and serum 1,25
(OH )2 vitamin D3 (calcitriol, normal range 25-79 pg/ml)
were measured by radioimmunoassay (Nichols Institute, San
Juan Capistrano, California, USA).
In freshly voided 2-h fasting urines, pH was measured by
a Metrohm 654 pH-Meter (Metrohm, Herisau, Switzerland).
The fasting urines were analysed for Ca, P, Na, K, Cl, urea,
and crea by autoanalyser techniques. Hydroxyproline (OHP)
was assayed using a kit (Hypronosticon®, Organon Teknika,
Boxtel, The Netherlands), where OHP is coloured by the
Ehrlich's reagent and quantified photometrically after bind-
ing to an acid cation exchange resin, hydrolysis (16 h) and
oxidation. Urinary anion gap (AG), an indirect measure of
urinary ammonium concentration [23], was calculated as
[Na] + [K] —[Cl]. All 2-h fasting urine values are presented
in relation to urine creatinine concentration (mmol/mmol
ratio), except renal phosphate threshold (TmP/GFR), which
was derived from the nomogram of Walton and Bijvoet [24],
and OHP-E (umol/1 GF), which was calculated using the
formula OHPo/Creau x Creas.
All values are presented as means ±SEM. Non-parametric
Mann-Whitney U-test for comparisons between and
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Wilcoxon signed-rank test for comparisons within groups
were used. Simple and multiple linear regression analysis was
performed for correlation studies.
Results
The 34 male RCSF participating in the study were
42.7 + 1.6 years old (range 23-64, not different from
controls). None of them had hypokalaemia
(<3.5 mmol/1), their fasting serum K concentrations
ranging between 3.5 and 4.5 mmol/1. Twenty-three
RCSF (67.6%) were normocitraturic (normo-cit),
whereas U a t x V was below 2.12mmol/day in
32.4% (combined low-/hypo-cit), i.e. low-cit
(1.70-2.11 mmol/day) in six (17.6%) and hypo-cit
(<1.70mmol/day) in five RCSF (14.8%). Among
patients classified as normo-cit, two of 23 had
UClt x V<2.12 mmol/day in one of their two urine
collections. Four of six RCSF with low-cit had urinary
citrate < 2.12 mmol/day in only one urine collection,
whereas four of five RCSF classified as hypo-cit had
U a t x V< 1.70 mmol/day in both 24-h urines. Among
healthy volunteers, urinary citrate < 2.12 mmol/day
occurred in 19 of 107 normal controls (17.8%), i.e. 12
(11.2%) had hypo-cit and 7 (6.5%) low-cit. Twelve
RCSF had hypercalciuria (HCSF), and 22 were normo-
calciuric (NCSF). Dietary protocols from 31 RCSF
(91.2%) were available to us for further analysis; three
of them (in 3 RCSF with normo-cit) were inappropri-
ately filled out.
Twenty-four-hour urine data
Table 1 summarizes the main parameters derived from
24-h urine collections in RCSF. With the exception of
Gl-alkali, which was only 14±4 mEq/day in hypo-cit
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compared with 36 ± 5 mEq/day in normo- and
39 ±7 mEq/day in low-cit, P<0.05 and < 0.025
respectively, none of the parameters was different
between subgroups. When comparing the combined
low-/hypo-cit group (UClt x V < 2.12 mmol/day, n = 11)
with normo-cit, however, dietary fibre intake was lower
in the former ones (11.9 ±1.6 g/day versus 18.3 ±1.8,
P=O.O37), and so was U^ x V (6.51 ±0.84 mmol/day
versus 9.41 ±0.81, P = 0.029).
Table 2 summarizes important correlations between
UCu x V and various other parameters. Positive cor-
relations between Uc,t
 x V and Scre,, CCTea, U^ x V,
UMg x V and Gl-alkali as well urine volume and dietary
fibre intake were noted. Among the 107 male controls,
citrate excretion was also positively, though less
strongly, correlated with urine volume (r = 0.240, P =
0.014). Figure 1 demonstrates that fibre consumption
below 10 g/day was always associated with low- or
hypo-cit, whereas RCSF whose fibre consumption was
>22.5g/d all were normocitraturic. In RCSF whose
fibre consumption was between 10 and 22.5 g/day, an
Table 2. Simple linear correlations between UQ, X V and other para-
meters in all 34 RCSF
y axis
U a i xV
x axis
S-Crea
Volume
Uc.xV
UM,XV
U K X V
Gl-alkali
Fibre intake
r value
0.490
0.440
0.440
0.570
0.370
0.280
0.470
0.460
slope
-0.04
0.02
0.0001
0.15
0.24
0.01
0.02
0.02
P
0.003
0.010
0.009
0.0004
0.032
0.111, NS
0.006
0.009
S-Crea, fasting serum creatinine before NH4C1 loading. NS, not
significant.
Table 1. Twenty-four-hour urine data (mean±SEM) from 34 RCSF.
Measurement
UU lxV
U c x V
Uo, x V (umol/day)
U r xV
UUre,xV
Usolph * V
UN,X V
UKxV
U a x V
UM,XV
Volume (ml)
Ucr«. X V
Ccn, (ml/min/1.73 m2)
Gl-alkali (mEq/day)
Fibre intake (g/day)
Normo-cit
(n = 23)
3.07 ±0.15
9.41 ±0.81
334 ±27
32.9 ±1.7
415±16
3.60±0.15
21.911.3
233± 17
63 ±4
229± 17
4.64 ±0.34
2051 ±158
15.5±0.5
109.7 ±4.4
36±5
18.3±1.8
Low-cit
(i = 6)
1.94±0.05*»
6.67 ±0.8
358±17
31.7±2.8
397±17
3.40 ±0.22
21.3±1.0
193114
73±7
191±14
3.77±0.42
1654±214
15.1 ±0.9
103.618.0
39±7
12.6±2.5
Hypo-cit
(» = 5)
1.18±0.23
6.31 ±1.65
31O±80
33.1 ±8.0
387±45
3.50 ±0.59
21.712.3
177141
55±10
178141
3.67 ±0.61
1399 + 332
15.311.7
114.4117.2
14±4°
11.012.0
All values except UQ, X V (umol/day), volume (ml), Gl-alkali (mEq/day) and fibre intake (g/day) are mmol/day. For abbreviations, see
'Methods'. Cit, urinary citrate excretion rate; Hypo-cit, < 1.70mmol/day; Low-cit, 1.70-2.11 mmol/day. + /><0.05 versus Normo-cit;
° /><0.025 versus Low-cit; °° /><0.01 versus low-cit; ** /J<0.001 versus normo-cit. In the combined low-/hypo-cit group, fibre intake was
lower than in normo-cit (11.9±1.6 versus 18.3± 1.8 g/day, /" = 0.037).
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O
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Fig. 1. 24-h urinary citrate excretion rate (y axis) in relation to daily
intake of vegetable fibres calculated from dietary protocols (x axis).
Circles, RCSF with UCit x V<2.12mmol/day (<400 mg/day) (/i =
11); triangles, RCSF with normocitraturia (/i = 20; three RCSF
missing due to inappropriately returned dietary protocols).
abnormality of urine acidification (see paragraph on
NH4C1 loading) occurred in six of seven with low-
/hypo-cit, but only in three of 14 with normo-cit
(P=0.034, Chi-square). There was only a trend for a
positive correlation between urinary excretion rates of
citrate and potassium, whereas no correlations were
found between UClt x V and urinary markers of protein
intake (Urea, UA, Sulph) as well as of sodium con-
sumption (r = 0.280, P = 0.l05).
In a multiple regression analysis, UCit x V in RCSF
was positively correlated (r = 0.700, P- 0.004) with a
combination of the four factors CcrM (partial F = 2.9),
urine volume (partial F = 0.1), Gl-alkali (partial F =
3.2) and dietary fibre consumption (partial F = 6.5).
When correlating urinary citrate with only Gl-alkali
and dietary fibres combined, a positive correlation was
again noted (r = 0.600, P=0.002); partial F values
were 6.5 for Gl-alkali and 6.0 for dietary fibre intake
respectively.
Since UCit x V was positively correlated with UQ, X V,
RCSF were divided into hypercalciurics (HCSF,
U a x V>9.00 mmol/day, n = 12) and normocalciurics
(NCSF, n = 22). Table 3 summarizes values of 24-h
urine excretion rates, CCTem, Gl-alkali and daily fibre
intake in HCSF and NCSF. UC l txV was higher in
HCSF than in NCSF; low-cit, however, occurred in
two of 12 HCSF and nine of 22 NCSF (P=0.289, Chi-
square), and hypo-cit was found in one of 12 HCSF
and four of 22 NCSF (/>=0.788, Chi-square). Also
elevated in HCSF versus NCSF were excretion rates
of Ox, P, urea, Sulph, Mg, urinary volume, CCTem and
daily fibre consumption. Since values of CCTra were
higher among HCSF, urinary parameters were also
expressed relative to creatinine (mmol/mmol ratios);
after this calculation, significant differences between
HCSF and NCSF remained for Ca/Crea, P/Crea, and
645
TaWc3. Differences between hypercalciuric (HCSF) and normocal-
ciuric (NCSF) recurrent calcium stone formers
Measurement
Uo,xV
Uc.xV
UcxVOimol/d)
UpxV
U r a x V
UUAxV
U^xV
U N . X V
UKxV
U a x V
UM.xV
Volume (ml)
UraxV
Ccr» (ml/min/
1.73 m2)
Gf-alkah (mEq/day)
Fibre intake (g/day)
HCSF (12)
3.19 ±0.29
13.00 ±0.50
394±40
38.4 ±2.8
447±21
3.73±0.17
24.1 ±1.6
255 ±27
67±5
249 ±28
5.75 ±0.40
2232 ±178
16.4 ±0.8
120.3 ±7.6
42.4 ±7.0
20.2 ±2.8
NCSF (22)
2.27±0.17
6.00±0.35
303 + 23
29.5 ±1.7
386+14
3.45±0.18
20.5 ±1.0
197±14
62 ±4
196 ± 13
3.63 + 0.22
1696 ±161
14.9±0.5
103.4 + 4.2
28.7 ±3.9
13.9±1.4
P
0.014
0.0001
0.046
0.011
0.028
0.313, NS
0.020
0.052, NS
0.576, NS
0.105, NS
0.0003
0.019
0.171, NS
0.040
O.W9, NS
0.035
All values are means ±SEM; P values are for differences between
HCSF and NCSF (Mann-Whitney U test). For abbreviations, see
'Methods' and Table 1.
Mg/Crea, whereas they disappeared for Cit/Crea
(P = 0.066), Ox/Crea, Urea/Crea, and Sulph/Crea. A
positive correlation was also noted between daily fibre
intake and U a xV (r = 0.440, P = O.O14).
Fasting blood and urine samples before/after NHACl
loading
Table 4 summarizes the most important fasting blood
and 2-h urine acid-base parameters in controls as well
as in RCSF with normo-cit, low-cit and hypo-cit before
and after NH4C1. Among stone formers with low-cit
and hypo-cit, serum anion gap was higher than in
controls and RCSF with normo-cit, both before and
after NH4C1 loading. During NH4C1 loading there was
a trend for venous bicarbonate concentration to
slightly decrease in the four groups, limit of significance
TaWe4. Fasting acid-base parameters and urinary cit/crea ratios
(means ±SEM) before and after NH4CI loading in 14 healthy male
controls and 34 RCSF
Measurement Controls
(n=14)
Normo-cit Low-cit Hypo-cit
(n = 23) (n = 6) (n = 5)
AG0 (mM)
AG3 (mM)
Bic.0(mM)
Bic3 (mM)
Urine pH0
Urine pH3
AG/Creao
AG/Crea3
Cit/Creao
Cit/Crea3
10.3±0.7
10.2±10
25.9±0.7
24.8 ±0.5
5.93 ±0.23
4.94 ±0.05
3.34±0.80
0.32 ±0.43
0.18 ±0.02
O.IO±O.O2
12.2 ±0.8
11.8 ±0.8
24.9 ±0.5
23.8 ±0.6
6.07 ±0.16
5.08 + 0.04t
3.53 ±0.41
0.02 ±0.31
0.19 ±0.02
0.10±0.01
13.4±0.7t
17.3±2.3t
26.7 ±0.7
19.7±2.0t
6.26 ±0.18
5.27 ±0.07*
4.66 ±0.95
1.05 ±0.48
0.10±0.01t
0.04 ±0.0 I f
16.8 ± 1 . 4 "
16.7±0.6*
24.8 ±1.4
21.8±1.0
5.78±0.16
5.28±0.10t
3.21 ±0.88
1.26±0.38
0.11 ±0.04
0.04±0.01°
AG, serum anion gap; bic, venous bicarbonate. ° /><0.05;
+ /><0.025; * P<0.0\; ** /><0.005 versus healthy controls.
Underlined values were significantly different from corresponding
values before NH4C1 loading (P<0.05, Wilcoxon signed-rank test).
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being reached in controls and in RCSF with low-cit
or hypo-cit. Urine pH was not significantly different
between subgroups on day 0; it uniformly fell upon
acid loading, but less markedly in RCSF than in
controls. Urine anion gap/creatinine ratios also were
similar between subgroups on day 0; after NH4C1 they
fell sharply in all subgroups, as did urine Cit/Crea
ratios. The latter ones were abnormally low in RCSF
with low-cit or hypo-cit, i.e. they had 'fasting
hypocitraturia'.
Figure 2 is a scatter plot of fasting venous bicarbon-
ate concentrations versus urine pH values after NH4C1
loading; the shaded area is a nomogram obtained in
23 healthy volunteers. Urine pH decreased below 5.32
and venous bicarbonate remained above 20.5 mmol/1
in all the normal subjects. However, 18 of the 34 RCSF
that we studied fell out of the nomogram: two normoci-
traturics, with urine pH values of 4.84 and 5.03 in the
face of blood bicarbonate concentrations of about
28 mM, were considered to be normal. In one RCSF
with low-cit, venous bicarbonate after NH4C1 loading
was inadvertently not determined; however, since his
urine pH decreased from 6.67 to 5.49 after acid loading
while his serum chloride concentration rose from 104
to 106 mmol/1, he was considered abnormal, but not
depicted in Figure 2. Thus, 16 of 34 RCSF (47.1%)
had an abnormality in urine acidification, characterized
either as insufficiently acidic urines in the presence of
normal venous bicarbonate concentrations, or as
sufficiently acidic urines at the expense of sys-
temic acidosis (venous bicarbonate concentration <
20.5 mmol/1), or both. Abnormal urine acidification
occurred in 10 of 11 RCSF with low-/hypo-cit, but
only in six 23 with normo-cit (P = 0.0004, Chi-square);
Ucit x V tended to be inversely correlated with fasting
urine pH after NH4C1 loading (r=-0.300, P = 0.064).
The prevalence of abnormal urinary acidification was
similar amongst HCSF (7 of 12) and NCSF (9 of 22,
P = 0.33\ versus HCSF, Chi-square).
Serum phosphate concentration was moderately
ffi
•z s o - •
3
14 IS IS 20 22 24 2S 28
Venous Bio. (mmol/1)
Fig. 2. Fasting urine pH (y axis) in relation to venous bicarbonate
(.x axis) after NH4C1 (0.1 mEq/kg BW/day for 3 days) in 23 healthy
men (shaded area) and 33 stone formers. Triangles, normo-cit;
circles, low-cit; framed circles, hypo-cit; one RCSF with low-cit and
urine pH of 5.49 not shown because of missing value of venous
bicarbonate concentration.
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lower (0.84 + 0.03 versus 0.98±0.04 mmol/1, P<0.05)
and serum intact PTH concentration higher (33.0±3.2
versus 25.0±2.1 pg/ml, P<0.05) in RCSF with hypo-
cit versus controls. Only before NH4C1 loading were
TmP/GFR values lower in RCSF with normo-cit
(0.76±0.03, /)=0.006) and in those with low-cit
(0.79 ±0.03 mmol/1 GF, F = 0.028) than in controls
(0.95 ±0.04 mmol/1 GF). All other blood and urine
parameters of calcium phosphate and bone metabolism
were similar in controls and the three subgroups of
RCSF, and they were not differently affected by acid
loading in controls and in the various subgroups of
RCSF (data not shown).
Table 5 compares parameters of calcium phosphate
metabolism between healthy controls and RCSF classi-
fied either as HCSF or NCSF, before and after acid
loading. Compared with controls, TmP/GFR was
lower both in HCSF and NCSF, and HCSF had lower
serum P and higher urine Ca/Crea both before and
after acid loading. In comparison with NCSF, serum
calcitriol and urine Ca/Crea were higher in HCSF.
Serum parameters and urine Ca/crea were unaffected
by acid loading, whereas TmP/GFR fell slightly in
NCSF and OHP-E rose in HCSF.
Frequencies of risk factors for low citraturia
When comparing normocitraturic RCSF with the com-
bined group of those with low-/hypo-cit, i.e. all RCSF
with UCltx V<2.12 mmol/day (<400 mg/day), abnor-
mal urine acidification was significantly more frequent
among the latter ones (10 of 11 versus six of 23 in
normo-cit, P = 0.0004, Chi-square). Low urine volume
was found in 27.3% of RCSF with low-/hyporcit,
compared with 8.7% in those with normo-cit (NS, Chi-
square); 18.2% of RCSF with low-/hypo-cit and 17.4%
Table 5. Parameters of calcium phosphate and bone metabolism in
fasting blood and urine samples of male controls, HCSF and NCSF
before and after NH4C1 loading
Measurement
Ca2 + o(mM)
Ca2 + 3(mM)
S-Po (mM)
S-P3 (mM)
I-PTH0(pg/
l-PTH3ml)
l,25-D30(pg/
1,25-D33ml)
Ca/Creao
Ca/Crea3
TmP/GFRo (mmol/
TmP/GFR3 1 GF)
OHP-Eo (jimol/
OHP-E3 1 GF)
Controls
(n=14)
1.27±0.01
1.26±0.01
0.98 ±0.04
0.95 ±0.05
25.0 ±2.1
28.7±3.l
50.5 ±5.1
53.8±4.9
0.25 ±0.02
0.34 ±0.05
0.95 ±0.04
0.84 ±0.05
1.10±0.l3
1.44±0.30
HCSF
(n=12)
l.27±0.01
1.26 ±0.02
0.82±0.04t
0.77±0.04t
27.2 ±3.3
26.5 ±3.0
65.3 ±4.5
67.2 ±3.8°
0.46 ±0.06**
0.53 ±0.04*
0.73 ±0.05**
0.69 ±0.04°
1.66 ±0.29
2.28 ±0.50
NCSF
(n = 22)
1.26±0.01
1.27±0.01
0.88 ±0.03
0.86 ±0.03
27.8 ±2.0
30.5±2.5
49.4 ±3.3
50.4 ±3.5
0.31 ±0.03
0.37±O.O4
O.79±O.O3t
0.73 ±0.02
1.67 ±0.13*
1.59 ±0.27
P
NS
NS
NS
NS
NS
NS
0.018
0.007
0.021
0.004
NS
NS
NS
NS
I-PTH, intact PTH; I.25-D3, calcitriol; TmP/GFR, renal phosphate
threshold; OHP, hydroxyproline. Indicated P values are for compar-
isons between HCSF and NCSF. ° /><0.05; + />< 0.025; * /><0.01;
** /'<0.005 versus healthy controls. Underlined values were signi-
ficantly different from corresponding values before NH4CI loading
(/><0.05, Wilcoxon signed-rank test).
Low urinary citrate and calcium nephrolithiasis
of those with normo-cit had Gl-alkali below
15 mEq/day; low fibre intake was present in 63.4% of
RCSF with low-/hypo-cit and in 50.0% of those with
normo-cit (NS, Chi-square). As shown in Figure 3,
two or more risk factors for decreased citraturia
occurred simultaneously in only 17.4% of RCSF with
normo-cit (4 of 23), whereas it did so in 72.7% of
RCSF with low-/hypo-cit (8 of 11, P=0.002 versus
normo-cit, Chi-square).
Discussion
Among the 34 recurrent calcium stone formers studied
herein under free-choice diet, overt hypocitraturia
(< 1.70 mmol/day) occurred in 15% and 'low citraturia'
(1.70-2.11 mmol/day) in another 18%. In the past
'idiopathic' hypocitraturia has been reported in
19-63% of patients with nephrolithiasis, either as an
isolated disorder or in association with other urinary
risk factors of stone formation [25]. Thus the preval-
ence obtained in the present study lies within the
expected range inasmuch as patients with obvious
causes of hypocitraturia, such as chronic diarrhoea,
overt renal tubular acidosis, hypokalaemia, renal
insufficiency and urinary tract infection [2] all had
been carefully excluded from this study.
Four main risk factors, occurring separately or in
combination, may be associated with low urinary cit-
rate excretion and deserve further consideration: an
abnormality in renal handling of acid, decreased net
Gl-alkali absorption, low dietary fibre consumption,
and low urinary volume.
Previously, we had provided evidence for increased
frequency of incomplete RTA among calcium stone
formers with hypocitraturia [6]. The study, however,
had been carried out under 'heavy' acid loading. In
the present approach we wanted to evaluate acid-base
metabolism under more 'physiological' conditions of
acid loading than originally described [26]; therefore
we applied only 0.05 g (0.95 mEq) NH4C1 per kg BW
daily in three divided doses given for 3 consecutive
80
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Fig. 3. Frequencies of occurrence of 0, 1, 2, 3, or 4 simultaneous
risk factors (RF) for low citraturia (<2.12 mmol/day) in RCSF. +,
<0.05 versus normo-cit (Chi-square).
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days. Nevertheless our healthy controls lowered their
urine pH below 5.32, about the same level as that
originally described by Wrong and Davies [26], despite
3 days of lighter acid loading. Forty-one percent of all
RCSF either were unable to do so, or they only did it
at the cost of metabolic acidosis. Both patterns reflect
diminished and/or retarded renal excretion of acid.
That the latter predisposes to hypocitraturia (in that
case via intracellular acidosis) is supported by the fact
that the defect in urinary acidification was significantly
more frequent among RCSF with low citraturia or
overt hypocitraturia (10 of 11) than among those with
normocitraturia (4 of 23, P=0.0004, Chi-square).
Our study confirms the rinding by Pak [1] that
urinary citrate excretion correlates with net G-I alkali
absorption, when assessed indirectly from non-
combustible urinary cations and anions [22]. In this
study r Gl-alkali absorption was particularly low in
RCSF with overt hypocitraturia (14+4 mEq/day).
Since alkali intake, as estimated from dietary fibre
consumption, was comparable to that observed in
RCSF with low- and normo-cit, alkali absorption itself
may have been reduced in RCSF with hypo-cit.
Alternatively, hypocitraturia might have resulted—at
least in some RCSF—from reduced intestinal absorp-
tion of citrate itself, as described by Cowley et al. [27].
Animal protein excess is often regarded as a risk
factor for hypocitraturia [1,9], by virtue of the organic
acid load that this type of diet conveys. In this study,
however, we did not find any significant correlations
between \Jai x V and the urinary markers of protein
intake, e.g. urea, uric acid, and sulphate. Reasons for
that are unclear. However, it has to be noted that the
studies usually referred to in the context of protein-
induced hypocitraturia (quoted in [1] and [9]) actually
describe increases in citraturia within the normal range
of daily urinary citrate excretion after dietary restric-
tion of protein.
We also confirm our previous finding of higher
Uc i txV in HCSF, compared with NCSF [28]. This
seems to be partially related to higher C^ values in
HCSF. There is, however, another potential explana-
tion for the finding: urinary excretion rate of citrate
was positively correlated with urinary excretion rates
of calcium, as previously demonstrated by others
[7,29], as well as with that of magnesium. Citrate
forms soluble complexes with both ions, and such
complexes cannot be absorbed along the nephron [13]:
thus the higher the filtered load of calcium or magnes-
ium, the higher the urinary output of citrate.
Two original observations are provided by the pre-
sent study. First, dietary intake of vegetable fibres is
reduced in RCSF with low-/hypo-cit, and a positive
correlation exists between urinary citrate excretion and
fibre intake. The prevalence of calcium nephrolithiasis
is known to be inversely related to dietary fibre intake
[30], and stone formers have been reported to ingest
less fibres than the normal population [31]. Until now,
however, the mechanism governing this association
had remained unknown, an intestinal hyperabsorption
of calcium consecutive to insufficient binding of the
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ion due to missing fibres with subsequent hypercalciu-
ria being the most widely postulated mechanism [30].
If such was the case, HCSF ought to have lower fibre
intake than NCSF. The opposite, however, was
observed in this study: fibre consumption was higher
in HCSF, and urinary calcium and fibre consumption
were positively, not negatively correlated. Therefore,
the intestinal hyperabsorption of calcium that we must
postulate in HCSF was not the consequence of missing
fibres, but most probably of increased calcitriol levels,
as generally accepted (reviewed in [32]) and observed
also in the present study. Since dietary fibres emerge
as a source of alkali [20], our finding rather suggests
that increased fibre ingestion protects against calcium
renal stone disease by raising urinary citrate excretion.
The other contribution of this study is the demon-
stration that a positive correlation exists between urin-
ary citrate and urinary volume. The mechanism behind
this association remains speculative but might involve
the impact of the proximal luminal flow rate on
bicarbonate reabsorption. Indeed, net bicarbonate
reabsorption positively correlates with luminal flow
rate along the proximal tubule [33-35], due to flow-
dependent stimulation of proton secretion by proximal
tubular cells [35]. Thus at higher flow rates, cytosolic
pH might rise, which in turn is expected to lower
citrate uptake by those cells and increase urinary citrate
excretion [3].
In conclusion the present study allows to rank the
most relevant causes for 'idiopathic' hypocitraturia:
incomplete RTA, reduced net Gl-alkali absorption,
low vegetable fibre intake and low urinary volume.
Whereas incomplete RTA, the most prevalent risk
factor among RCSF with low citrate excretion, and
reduced Gl-alkali absorption had already been widely
discussed in the past, low vegetable fibre intake and
low urinary volume had gone unnoticed so far.
Moreover in an individual stone former idiopathic
hypocitraturia appears to be of multifactorial origin.
Given the fact that most of these causes are readily
accessible to dietary advices and medical treatment,
they should be carefully looked for in recurrent idio-
pathic calcium stone formers.
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